Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Arrhythmia Market In 2029?
In recent times, the size of the arrhythmia market has seen robust growth. The market is set to escalate from $7.8 billion in 2024 to $8.28 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to the growth during the historic period include a surge in lifestyle-related risk conditions, a rise in heart diseases, advancements in implantable apparatus, a worldwide increment in cardiac surgeries, heightened demand for remote surveillance, and progressive research and development in antiarrhythmic pharmaceuticals.
The market for arrhythmia is predicted to expand significantly in the coming years, with an expected value of $11.65 billion by 2029 at a CAGR of 8.9%. This projected growth in the subsequent years can be ascribed to a rise in education and awareness, tailored medical treatments, increased electrophysiology labs, emphasis on early diagnosis and prevention, genetic testing for hereditary arrhythmias, and improvements in healthcare infrastructure. Key trends forecasted in the approaching period involve innovations in heart monitoring technologies, telemedicine, and remote patient monitoring, attention towards atrial fibrillation detection and handling, implantable devices for managing arrhythmia, advancements in ECG monitoring apparatus, and a regulatory focus on medical device approvals.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8018&type=smp
What are the Fundamental Drivers and Innovations Shaping the Arrhythmia Market?
The escalating incidences of cardiac ailments and other heart-related issues are anticipated to fuel the expansion of the arrhythmia market in the future. Cardiac ailments or cardiovascular diseases encompass a cluster of heart and blood vessel disorders, inclusive of various conditions like atherosclerosis, heart attacks, strokes, and arrhythmias, to name a few. Both functional impairments, incorporating diastolic and systolic dysfunction, and electrical irregularities, encompassing the onset of arrhythmias, can lead to a high prevalence of cardiac failure, atrial fibrillation, and other heart ailments. For example, in October 2022, based on the data from the CDC (Centers for Disease Control and Prevention), a government agency in the US, the number of deaths due to heart diseases was reported to be about 69.7k and heart attacks were approximately 80.5k annually. Therefore, the escalating incidences of cardiac ailments and other heart-related conditions are propelling the growth of the arrhythmia market.
How Is the Arrhythmia Market Segmented?
The arrhythmiamarket covered in this report is segmented –
1) By Type: Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types
2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor
3) By Hearth Blocks: First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Supraventricular Tachycardias: Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT)
2) By Ventricular Arrhythmias: Ventricular Fibrillation, Ventricular Tachycardia, Premature Ventricular Contractions (PVCs)
3) By Bradyarrhythmias: Sinus Bradycardia, Heart Block
4) By Other Types: Long QT Syndrome, Wolff-Parkinson-White Syndrome, Torsades de Pointes
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8018&type=smp
Which Regions Are Driving the Next Phase of the Arrhythmia Market Growth?
North America was the largest region in the arrhythmia market in 2024. The regions covered in the arrhythmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Arrhythmia Market?
A major trend in the arrhythmia market is the development of new therapies for treatment. Key players in the market are progressing in their efforts to introduce novel treatments, an example being cryoablation therapy, which is emerging as a transformative therapy for arrhythmia patients. In August 2023, CardioVisio for Atrial Fibrillation was launched by GE HealthCare, a prominent U.S. medical technology firm. This digital support tool, geared towards clinical decisions from a patient-centered perspective, is designed to enable precision care. By employing sophisticated data analytics and integrating patient insights, CardioVisio assists health experts in gaining a better understanding and control of atrial fibrillation, a typical heart ailment. With its offering of customized care plans and real-time data monitoring, this tool aspires to enhance the precision of treatment solutions and elevate patient results, constituting a significant advancement in the administration of heart care.
View the full report here:
https://www.thebusinessresearchcompany.com/report/arrhythmia-global-market-report
How Is the Arrhythmia Market Defined and What Are Its Core Parameters?
Arrhythmia refers to a heart disorder caused by an abnormality in the normal sequence of electrical impulses, which changes the rate or rhythm at which the heart beats. Electrical impulses can be too fast, too slow, or erratically occurring, resulting in irregular heartbeats.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8018
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model